Actively Recruiting
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
Led by University of California, Los Angeles · Updated on 2026-04-16
100
Participants Needed
1
Research Sites
487 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Sonablate HIFU device was approved by the U.S.FDA for prostate tissue ablation in October, 2015. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using HIFU through clinical data and health-related quality of life (HRQOL) questionnaires.
CONDITIONS
Official Title
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 40 years to 85 years
- Subject has elected or already undergone HIFU therapy as their standard of care treatment method and declined alternative treatment (active surveillance, radical prostatectomy, radiation therapy, cryosurgery and hormone therapy)
- PSA 64 20
- Prostate volume of 64 70 cc
- Ability to complete informed consent form
You will not qualify if you...
- Prior treatment for prostate cancer (with the exception of androgen deprivation therapy)
- Medical contraindication to follow-up multiparametric MRI or prostate biopsy
- Unable to tolerate general or regional anesthesia
- Positive bone scan (only if bone scan has been done or clinically indicated)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, Los Angeles
Los Angeles, California, United States, 90095
Actively Recruiting
Research Team
M
Michelle C Cardenas, MSN, NP
CONTACT
A
Ankush sachdeva
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here